23.59
price up icon7.13%   1.57
after-market Dopo l'orario di chiusura: 23.68 0.09 +0.38%
loading
Precedente Chiudi:
$22.02
Aprire:
$21.73
Volume 24 ore:
816.41K
Relative Volume:
0.97
Capitalizzazione di mercato:
$1.40B
Reddito:
-
Utile/perdita netta:
$-107.85M
Rapporto P/E:
-10.67
EPS:
-2.21
Flusso di cassa netto:
$-106.82M
1 W Prestazione:
-8.95%
1M Prestazione:
-21.18%
6M Prestazione:
-43.50%
1 anno Prestazione:
-42.25%
Intervallo 1D:
Value
$21.45
$23.69
Intervallo di 1 settimana:
Value
$21.45
$26.89
Portata 52W:
Value
$21.45
$51.61

Vera Therapeutics Inc Stock (VERA) Company Profile

Name
Nome
Vera Therapeutics Inc
Name
Telefono
650-770-0077
Name
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-08
Name
Ultimi documenti SEC
Name
VERA's Discussions on Twitter

Confronta VERA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VERA
Vera Therapeutics Inc
23.59 1.40B 0 -107.85M -106.82M -2.21
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-04 Iniziato Wolfe Research Outperform
2025-01-28 Iniziato Goldman Buy
2024-11-21 Iniziato Wells Fargo Overweight
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-01-25 Iniziato Oppenheimer Outperform
2024-01-08 Iniziato Cantor Fitzgerald Overweight
2023-12-18 Iniziato Raymond James Outperform
2023-11-10 Aggiornamento Jefferies Hold → Buy
2023-08-16 Iniziato Guggenheim Buy
2023-01-04 Downgrade Jefferies Buy → Hold
2023-01-04 Downgrade Wedbush Outperform → Neutral
2022-07-12 Iniziato JP Morgan Overweight
2022-05-02 Iniziato H.C. Wainwright Buy
2022-04-19 Iniziato Wedbush Outperform
Mostra tutto

Vera Therapeutics Inc Borsa (VERA) Ultime notizie

pulisher
Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025
pulisher
Apr 01, 2025

Teacher Retirement System of Texas Acquires 3,942 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Vera Therapeutics (NASDAQ:VERA) Reaches New 1-Year LowWhat's Next? - MarketBeat

Mar 31, 2025
pulisher
Mar 29, 2025

69,724 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by Raymond James Financial Inc. - Defense World

Mar 29, 2025
pulisher
Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Vera Therapeutics validates Fair Value bearish call with 42% decline By Investing.com - Investing.com UK

Mar 26, 2025
pulisher
Mar 26, 2025

Swiss National Bank Purchases 15,700 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 26, 2025
pulisher
Mar 22, 2025

AlphaQuest LLC Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Bank of New York Mellon Corp Acquires 7,895 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

Is Vera Therapeutics (NASDAQ:VERA) Weighed On By Its Debt Load? - Simply Wall St

Mar 14, 2025
pulisher
Mar 14, 2025

Victory Capital Management Inc. Increases Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Buy” by Analysts - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Recommendation of “Buy” from Analysts - The AM Reporter

Mar 12, 2025
pulisher
Mar 12, 2025

Vera Therapeutics (VERA) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Growth Accelerates: 9 Strategic Hires Secure Equity Package Worth $2.3M - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MENAFN.COM

Mar 11, 2025
pulisher
Mar 08, 2025

What is HC Wainwright’s Estimate for VERA FY2025 Earnings? - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Vera Therapeutics: Does The Earlier Otsuka Launch Harm Its Prospects Much? - Seeking Alpha

Mar 07, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for VERA - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

JPMorgan Chase & Co. Has Lowered Expectations for Vera Therapeutics (NASDAQ:VERA) Stock Price - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $71.00 by Analysts at JPMorgan Chase & Co. - Armenian Reporter

Mar 05, 2025
pulisher
Mar 04, 2025

Vera Therapeutics Getting Closer To Key Technical Benchmark - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Rhumbline Advisers Has $2.48 Million Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Q1 EPS Estimates for Vera Therapeutics Boosted by Wedbush - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

(VERA) On The My Stocks Page - news.stocktradersdaily.com

Mar 02, 2025
pulisher
Mar 02, 2025

What is Wedbush’s Forecast for VERA FY2029 Earnings? - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Guggenheim Raises Vera Therapeutics (NASDAQ:VERA) Price Target to $61.00 - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 28, 2025
pulisher
Feb 27, 2025

Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $38, Maintains Neutral Rating - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Guggenheim raises Vera Therapeutics stock target to $61 - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Can Vera Therapeutics Reveal New Immunology Pipeline Updates at Upcoming TD Cowen Conference? - StockTitan

Feb 27, 2025
pulisher
Feb 26, 2025

Optimistic Buy Rating for Vera Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Vera Therapeutics targets Q2 for IgAN drug results, FDA filing By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Vera Therapeutics 2024 Loss Widens -February 26, 2025 at 08:53 am EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Vera Therapeutics targets Q2 for IgAN drug results, FDA filing - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (VERA) Vera Therapeutics Posts Full Year 2024 Total Operating Expenses $167.2M - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (VERA) Vera Therapeutics Posts Full Year 2024 Net Loss $-2.75 a Share, vs. FactSet Est of $-2.90 Loss - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Vera Therapeutics, Inc. Reports 2024 Business Highlights and Financial Results; On Track for Phase 3 ORIGIN Trial Results and FDA Submission for Atacicept in IgA Nephropathy - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Can Vera's Breakthrough IgAN Therapy Disrupt the $5B Kidney Disease Market? Phase 3 Results Coming Q2 2025 - StockTitan

Feb 26, 2025
pulisher
Feb 20, 2025

Vera Therapeutics’ Atacicept Positioned for Growth Amid Market Overreaction to Otsuka’s Sibeprenlimab - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

(VERA) Trading Advice - Stock Traders Daily

Feb 20, 2025
pulisher
Feb 19, 2025

Vera Therapeutics Inc (VERA) may enjoy gains as insiders got busy in the recent days - Knox Daily

Feb 19, 2025
pulisher
Feb 18, 2025

Cantor Fitzgerald maintains Overweight on Vera Therapeutics stock By Investing.com - Investing.com Nigeria

Feb 18, 2025
pulisher
Feb 18, 2025

Evercore ISI maintains Vera Therapeutics stock with $75 target By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Evercore ISI maintains Vera Therapeutics stock with $75 target - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Vera Therapeutics weakness on Otsuka plans ‘makes no sense,’ says Wells Fargo - MSN

Feb 18, 2025
pulisher
Feb 16, 2025

Vera Therapeutics stock drops amid rival drug update - MSN

Feb 16, 2025

Vera Therapeutics Inc Azioni (VERA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Capitalizzazione:     |  Volume (24 ore):